Study of MG-K10 for Teens with Moderate to Severe Eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a new injectable medication called MG-K10 for teens with moderate to severe eczema that hasn't been well controlled with creams. The goal is to see if it can safely reduce inflammation and improve skin symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old and weigh at least 30 kg (66 lbs).
- You have had eczema (atopic dermatitis) for at least 6 months, and it is moderate to severe (covering a large area of your body).
- You have tried prescription creams or ointments, but they didn't control your eczema well enough or weren't safe for you to use.
- You are willing to use effective birth control during the study and for 6 months after the last dose.
- You do not have any other active skin conditions (like psoriasis) that could affect the study results.
- You have not used certain strong medications for eczema or other conditions within the last few weeks or months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called AK120 for teenagers with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug can reduce itching and improve skin symptoms.
This study tests a new injected medication called XKH001 for people with moderate-to-severe atopic dermatitis (a type of eczema) that hasn't improved with standard creams. The goal is to see if it can reduce the severity of eczema and itching.
This trial tests a new injectable drug called SKB575 for people with moderate to severe atopic dermatitis (eczema). It aims to see how safe and effective the drug is, especially for those who haven't had success with strong creams or pills.
This study tests a new injectable medication called MG-K10 for people with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces itching and clears skin better than a placebo. If you've tried topical treatments without enough relief, this might be an option.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
This trial tests an investigational drug called BxC-I17e, given as an injection under the skin, for people with moderate to severe atopic dermatitis (eczema) that hasn't improved enough with standard creams. The goal is to see if it is safe and works well.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.